Interesting, I actually was under the impression that any incompatible cells within a host are attacked by ones immune system. Saying that, leronlimab suppresses CCR5 sites from sending signals to attack these foreign cells/organs but leronlimab is not permanently fixed to CD4 receptors and hence have to be replenished.
Hence a lifetime of leronlimab would be required..... or am I missing something here?